SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 419.51 |
| Enterprise Value ($M) | 389.07 |
| Book Value ($M) | 67.83 |
| Book Value / Share | 0.86 |
| Price / Book | 6.18 |
| NCAV ($M) | -78.41 |
| NCAV / Share | -0.99 |
| Price / NCAV | -5.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.97 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -1.21 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.03 |
| Current Ratio | 2.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 123.52 |
| Assets | 269.75 |
| Liabilities | 201.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 33.28 |
| Operating Income | -164.21 |
| Net Income | -147.79 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -104.50 |
| Cash from Investing | 23.48 |
| Cash from Financing | 54.53 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Adage Capital Management, L.P. | 6.77 | ||
| 13G/A | Johnson & Johnson | 8.60 | 0.00 | |
| 13D/A | Perceptive Advisors Llc | 16.40 | 10.96 | |
| 13G/A | Sanofi | 15.80 | 159.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 96,387 | 371,903 | 25.92 | |
| 67,151 | 229,093 | 29.31 | |
| 82,943 | 310,110 | 26.75 | |
| 137,631 | 540,210 | 25.48 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MCRB – Seres Therapeutics, Inc. | MDGL – Madrigal Pharmaceuticals, Inc. |
| MGNX – MacroGenics, Inc. | MIST – Milestone Pharmaceuticals Inc. |
| MLYS – Mineralys Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io